2019 Progress In Ht-1 Newborn Screening Sobi presented an update on the state of newborn screening for Hereditary Tyrosinemia Type 1 (HT-1) in the United States during the Association of Public Health Laboratories’ (APHL) 2019 Newborn Screening and Genetic Testing Symposium, April 7-10 in Chicago. A 2015 Sobi-sponsored study showed 78% (39 of 50) of […]
2019 PROGRESS IN HT-1 NEWBORN SCREENING Read More »
Covid-19 Update From Cycle Regarding Nityr At Cycle Pharmaceuticals, the health and safety of patients with tyrosinemia type 1 (HT-1) is our top priority. As the Coronavirus increases in worldwide prevalence, please have full confidence that the supply chain for NITYR® (nitisinone) Tablets is fully organized and managed to serve patients with HT-1 and their
Covid-19 Update From Cycle Regarding Nityr Read More »
Covid-19 Update From Cambrooke Foods To all our Cambrooke customers and friends, Nothing at Cambrooke is more important to me than your well-being and that of our Cambrooke team. In response to the rapidly evolving COVID-19 virus, I want to assure you that we have taken several measures in order to faithfully ensure uninterrupted delivery
COVID-19 UPDATE FROM CAMBROOKE FOODS Read More »
Cycle Pharmaceuticals Launches New Informative Online Meeting Series For Patients With Tyrosinemia Type 1 In The Us Boston (MA), USA, April 13, 2020 – Cycle Pharmaceuticals (“Cycle”) is pleased to announce the launch of a new online meeting series for patients and their families with Hereditary Tyrosinemia Type 1 (HT-1) in the US. The meeting
A Message From Our Ceo At Nutricia North America On Covid-19 Dear Nutricia Customers and Community, At Nutricia, we know that our customers, patients, and their families rely on our medical foods every day. The health and safety of our customers and patients have always been our highest priority. As the COVID- 19 situation continues
A MESSAGE FROM OUR CEO AT NUTRICIA NORTH AMERICA ON COVID-19 Read More »
Vitaflo Covid-19 Statement https://www.nestlehealthscience.us/vitaflo-usa
VITAFLO COVID-19 STATEMENT Read More »
Sobi Statement On Covid-19 At Sobi, patient care is of the utmost importance in everything we do. We understand that people living with rare and complex conditions around the world rely on the safe and secure supply of our treatments every day. We are committed to taking all appropriate steps to secure an uninterrupted supply
SOBI STATEMENT ON COVID-19 Read More »
